作者：
Xie, Stanley C. [1]
;
Gillett, David L. [2]
;
Spillman, Natalie J. [1]
;
Tsu, Christopher [1]
;
Luth, Madeline R. [3]
;
Ottilie, Sabine [2]
;
Duffy, Sandra [1]
;
Gould, Alexandra E. [4]
;
Hales, Paul [1]
;
Seager, Benjamin A. [3]
;
Charron, Carlie L. [5]
;
Bruzzese, Frank [1]
;
Yang, Xiaofeng [6]
;
Zhao, Xiansi [1]
;
Huang, Shih-Chung [2]
;
Hutton, Craig A. [5]
;
Burrows, Jeremy N. [5]
;
Winzeler, Elizabeth A. [5]
;
Avery, Vicky M. [5]
;
Dick, Lawrence R. [1]
;
Tilley, Leann [4]
作者单位：
Takeda Pharmaceut Int Co, Oncol Clin R&D, Cambridge, MA 02139 USA
[1]
UC San Diego Sch Med, Hostmicrobe Syst & Therapeut Div, La Jolla, CA 92093 USA
[2]
Griffith Univ, Griffith Inst Drug Discovery, Brisbane, Qld 4111, Australia
[3]
Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Sch Chem, Melbourne, Vic 3010, Australia
[4]
Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia
[5]
Med Malaria Venture, CH-1215 Meyrin, Switzerland
[6]
发布时间
2019-05-23
换一批
